Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SKYLA vs TOCILIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SKYLA vs TOCILIZUMAB: Safety Overview

Metric SKYLA TOCILIZUMAB
Total FAERS Reports 106 98,443
Deaths Reported 0 9,543
Death Rate N/A 9.7%
Hospitalizations 1 24,039
Average Patient Age 25.5 yrs 52.2 yrs
% Female Patients N/A 84.5%
Manufacturer N/A CELLTRION USA, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription